ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate

C25H27FN8O3 — CID 53476696

IUPACethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate
SMILESCCOC(=O)Nc1nc2c(-c3ncccc3F)cc(-c3cnc(NCCN4CCOCC4)nc3)cc2[nH]1
InChIInChI=1S/C25H27FN8O3/c1-2-37-25(35)33-24-31-20-13-16(12-18(22(20)32-24)21-19(26)4-3-5-27-21)17-14-29-23(30-15-17)28-6-7-34-8-10-36-11-9-34/h3-5,12-15H,2,6-11H2,1H3,(H,28,29,30)(H2,31,32,33,35)
InChIKeyZOFAKJWBXYNFIG-UHFFFAOYSA-N
MW506.54 g/mol
LogP3.53
Rot. Bonds8

About ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate

ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate (PubChem CID 53476696) has the molecular formula C25H27FN8O3 and a molecular weight of 506.54 g/mol. Its IUPAC name is ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate.

Molecular Properties

Compound Nameethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate
PubChem CID53476696
Molecular FormulaC25H27FN8O3
Molecular Weight506.54 g/mol
Exact Mass506.22
IUPAC Nameethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate
SMILESCCOC(=O)Nc1nc2c(-c3ncccc3F)cc(-c3cnc(NCCN4CCOCC4)nc3)cc2[nH]1
InChIInChI=1S/C25H27FN8O3/c1-2-37-25(35)33-24-31-20-13-16(12-18(22(20)32-24)21-19(26)4-3-5-27-21)17-14-29-23(30-15-17)28-6-7-34-8-10-36-11-9-34/h3-5,12-15H,2,6-11H2,1H3,(H,28,29,30)(H2,31,32,33,35)
InChIKeyZOFAKJWBXYNFIG-UHFFFAOYSA-N
XLogP3.53
TPSA130.18 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500506.54
LogP ≤ 53.53
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate?
The IUPAC name of ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate (CID 53476696) is ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate.
What is the SMILES notation for ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate?
The canonical SMILES for ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate is CCOC(=O)Nc1nc2c(-c3ncccc3F)cc(-c3cnc(NCCN4CCOCC4)nc3)cc2[nH]1.
What is the InChIKey of ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate?
The InChIKey is ZOFAKJWBXYNFIG-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27FN8O3/c1-2-37-25(35)33-24-31-20-13-16(12-18(22(20)32-24)21-19(26)4-3-5-27-21)17-14-29-23(30-15-17)28-6-7-34-8-10-36-11-9-34/h3-5,12-15H,2,6-11H2,1H3,(H,28,29,30)(H2,31,32,33,35).
What are the key properties of ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate?
ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate has a molecular weight of 506.54 g/mol, XLogP of 3.53, 8 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl N-[4-(3-fluoro-2-pyridinyl)-6-[2-(2-morpholin-4-ylethylamino)pyrimidin-5-yl]-1H-benzimidazol-2-yl]carbamate is sourced from PubChem (CID 53476696), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).